{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:50:49Z","timestamp":1794945049461,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["NIAMS K08AR071494"],"award-info":[{"award-number":["NIAMS K08AR071494"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["NCATS KL2TR0001856"],"award-info":[{"award-number":["NCATS KL2TR0001856"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antibiotic stewardship is viewed as having great public health benefit with limited direct benefit to the patient at the time of administration. The objective of our study was to determine if inappropriate administration of antibiotics could create conditions that would increase the rates of surgical infection. We hypothesized that sub-MIC levels of vancomycin would increase\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    growth, biofilm formation, and rates of infection.\n                    <jats:italic>S. aureus<\/jats:italic>\n                    MRSA and MSSA strains were used for all experiments. Bacteria were grown planktonically and monitored using spectrophotometry. Quantitative agar culture was used to measure planktonic and biofilm bacterial burden. A mouse abscess model was used to confirm phenotypes in vivo. In the planktonic growth assay, increases in bacterial burden at \u00bc MIC vancomycin were observed in USA300 JE2 by 72\u00a0h. Similar findings were observed with \u00bd MIC in Newman and SH1000. For biofilm formation, USA300 JE2 at \u00bc and \u00bd MIC vancomycin increased biofilm formation by approximately 1.3- and 2.3-fold respectively at 72\u00a0h as compared to untreated controls. Similar findings were observed with Newman and SH1000 with a 2.4-fold increase in biofilm formation at \u00bd MIC vancomycin. In a mouse abscess model, there was a 1.2-fold increase with sub-MIC vancomycin at 3\u00a0days post infection. Our study showed that Sub-optimal vancomycin dosing promoted\n                    <jats:italic>S. aureus<\/jats:italic>\n                    planktonic growth and biofilm formation, phenotypic measures of bacterial virulence. This phenotype induced by sub-MIC levels of vancomycin was also observed to increase rates of infection and pathogenesis in our mouse model. Risks of exposure to sub-MIC concentrations with vancomycin in surgical procedures are greater as there is decreased bioavailability in tissue in comparison to other antibiotics. This highlights the importance of proper antibiotic selection, stewardship, and dosing for both surgical prophylaxis and treatment of infection.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-30951-y","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:04:30Z","timestamp":1679382270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Dose optimization in surgical prophylaxis: sub-inhibitory dosing of vancomycin increases rates of biofilm formation and the rates of surgical site infection"],"prefix":"10.1038","volume":"13","author":[{"given":"Kimberly M.","family":"Brothers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance L.","family":"Thurlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata C.","family":"Byrapogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Urish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"30951_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/03009734.2014.904457","volume":"119","author":"L Sandegren","year":"2014","unstructured":"Sandegren, L. Selection of antibiotic resistance at very low antibiotic concentrations. Ups J. Med. Sci. 119, 103\u2013107. https:\/\/doi.org\/10.3109\/03009734.2014.904457 (2014).","journal-title":"Ups J. Med. Sci."},{"key":"30951_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1097\/CORR.0000000000000619","volume":"477","author":"SP Ryan","year":"2019","unstructured":"Ryan, S. P. et al. Is there a difference in infection risk between single and multiple doses of prophylactic antibiotics? A meta-analysis. Clin. Orthop. Relat. Res. 477, 1577\u20131590. https:\/\/doi.org\/10.1097\/CORR.0000000000000619 (2019).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"30951_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2106\/JBJS.18.00336","volume":"101","author":"TL Tan","year":"2019","unstructured":"Tan, T. L. et al. Perioperative antibiotic prophylaxis in total joint arthroplasty: A single dose is as effective as multiple doses. J. Bone Jt. Surg. Am. 101, 429\u2013437. https:\/\/doi.org\/10.2106\/JBJS.18.00336 (2019).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"30951_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.arth.2017.11.029","volume":"33","author":"KL Urish","year":"2018","unstructured":"Urish, K. L. et al. A multicenter study of irrigation and debridement in total knee arthroplasty periprosthetic joint infection: Treatment failure is high. J. Arthroplasty 33, 1154\u20131159. https:\/\/doi.org\/10.1016\/j.arth.2017.11.029 (2018).","journal-title":"J. Arthroplasty"},{"key":"30951_CR5","first-page":"50","volume":"29","author":"MQ Shah","year":"2017","unstructured":"Shah, M. Q. et al. Surgical site infection in orthopaedic implants and its common bacteria with their sensitivities to antibiotics, in open reduction internal fixation. J. Ayub Med. Coll. Abbottabad 29, 50\u201353 (2017).","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"30951_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0002-9343(86)90517-6","volume":"81","author":"B Sugarman","year":"1986","unstructured":"Sugarman, B. Infections and prosthetic devices. Am. J. Med. 81, 78\u201384. https:\/\/doi.org\/10.1016\/0002-9343(86)90517-6 (1986).","journal-title":"Am. J. Med."},{"key":"30951_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1302\/2058-5241.4.180092","volume":"4","author":"P Izakovicova","year":"2019","unstructured":"Izakovicova, P., Borens, O. & Trampuz, A. Periprosthetic joint infection: Current concepts and outlook. EFORT Open Rev. 4, 482\u2013494. https:\/\/doi.org\/10.1302\/2058-5241.4.180092 (2019).","journal-title":"EFORT Open Rev."},{"key":"30951_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli, W., Trampuz, A. & Ochsner, P. E. Prosthetic-joint infections. N. Engl. J. Med. 351, 1645\u20131654. https:\/\/doi.org\/10.1056\/NEJMra040181 (2004).","journal-title":"N. Engl. J. Med."},{"key":"30951_CR9","first-page":"651","volume":"66","author":"S Mohsen","year":"2020","unstructured":"Mohsen, S., Dickinson, J. A. & Somayaji, R. Update on the adverse effects of antimicrobial therapies in community practice. Can. Fam. Phys. 66, 651\u2013659 (2020).","journal-title":"Can. Fam. Phys."},{"key":"30951_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berrios-Torres","year":"2017","unstructured":"Berrios-Torres, S. I. et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 152, 784\u2013791. https:\/\/doi.org\/10.1001\/jamasurg.2017.0904 (2017).","journal-title":"JAMA Surg."},{"key":"30951_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhin.2016.12.016","volume":"95","author":"DJ Leaper","year":"2017","unstructured":"Leaper, D. J. & Edmiston, C. E. World Health Organization: Global guidelines for the prevention of surgical site infection. J. Hosp. Infect. 95, 135\u2013136. https:\/\/doi.org\/10.1016\/j.jhin.2016.12.016 (2017).","journal-title":"J. Hosp. Infect."},{"key":"30951_CR12","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2106\/JBJS.17.01485","volume":"100","author":"A Inabathula","year":"2018","unstructured":"Inabathula, A. et al. Extended oral antibiotic prophylaxis in high-risk patients substantially reduces primary total hip and knee arthroplasty 90-day infection rate. J. Bone Jt. Surg. Am. 100, 2103\u20132109. https:\/\/doi.org\/10.2106\/JBJS.17.01485 (2018).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"30951_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11999-016-4890-4","volume":"475","author":"JM Frank","year":"2017","unstructured":"Frank, J. M. et al. The Mark Coventry, MD, Award: Oral antibiotics reduce reinfection after two-stage exchange: A multicenter, randomized controlled trial. Clin. Orthop. Relat. Res. 475, 56\u201361. https:\/\/doi.org\/10.1007\/s11999-016-4890-4 (2017).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"30951_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/cid\/ciz261","volume":"70","author":"NB Shah","year":"2020","unstructured":"Shah, N. B. et al. Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection. Clin. Infect. Dis. 70, 559\u2013565. https:\/\/doi.org\/10.1093\/cid\/ciz261 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"30951_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/infdis\/157.1.71","volume":"157","author":"KH Schadow","year":"1988","unstructured":"Schadow, K. H., Simpson, W. A. & Christensen, G. D. Characteristics of adherence to plastic tissue culture plates of coagulase-negative staphylococci exposed to subinhibitory concentrations of antimicrobial agents. J. Infect. Dis. 157, 71\u201377. https:\/\/doi.org\/10.1093\/infdis\/157.1.71 (1988).","journal-title":"J. Infect. Dis."},{"key":"30951_CR16","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1128\/AAC.01565-09","volume":"54","author":"Q Wang","year":"2010","unstructured":"Wang, Q. et al. Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob. Agents Chemother. 54, 2707\u20132711. https:\/\/doi.org\/10.1128\/AAC.01565-09 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"30951_CR17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/jcp.2009.069021","volume":"62","author":"JS Cargill","year":"2009","unstructured":"Cargill, J. S. & Upton, M. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. J. Clin. Pathol. 62, 1112\u20131116. https:\/\/doi.org\/10.1136\/jcp.2009.069021 (2009).","journal-title":"J. Clin. Pathol."},{"key":"30951_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/nature03912","volume":"436","author":"LR Hoffman","year":"2005","unstructured":"Hoffman, L. R. et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171\u20131175. https:\/\/doi.org\/10.1038\/nature03912 (2005).","journal-title":"Nature"},{"key":"30951_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1365-2958.2009.06739.x","volume":"72","author":"A Boehm","year":"2009","unstructured":"Boehm, A. et al. Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol. Microbiol. 72, 1500\u20131516. https:\/\/doi.org\/10.1111\/j.1365-2958.2009.06739.x (2009).","journal-title":"Mol. Microbiol."},{"key":"30951_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1365-2672.2007.03653.x","volume":"104","author":"J Majtan","year":"2008","unstructured":"Majtan, J., Majtanova, L., Xu, M. & Majtan, V. In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia. J. Appl. Microbiol. 104, 1294\u20131301. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03653.x (2008).","journal-title":"J. Appl. Microbiol."},{"key":"30951_CR21","first-page":"221","volume":"31","author":"D Drenjancevic","year":"2007","unstructured":"Drenjancevic, D., Vranes, J., Bedenic, B. & Sakic-Zdravcevic, K. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains. Coll. Antropol. 31, 221\u2013225 (2007).","journal-title":"Coll. Antropol."},{"key":"30951_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1128\/AAC.41.5.906","volume":"41","author":"C Bisognano","year":"1997","unstructured":"Bisognano, C., Vaudaux, P. E., Lew, D. P., Ng, E. Y. & Hooper, D. C. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 41, 906\u2013913 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"30951_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1128\/aac.37.4.921","volume":"37","author":"H Carsenti-Etesse","year":"1993","unstructured":"Carsenti-Etesse, H. et al. Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob. Agents Chemother. 37, 921\u2013923. https:\/\/doi.org\/10.1128\/aac.37.4.921 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"30951_CR24","doi-asserted-by":"publisher","first-page":"i41","DOI":"10.1093\/jac\/dku251","volume":"69","author":"M Bassetti","year":"2014","unstructured":"Bassetti, M. et al. Current antibiotic management of prosthetic joint infections in Italy: The \u201cUdine strategy\u201d. J. Antimicrob. Chemother. 69(Suppl 1), i41\u2013i45. https:\/\/doi.org\/10.1093\/jac\/dku251 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"30951_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11999-016-4720-8","volume":"474","author":"KL Urish","year":"2016","unstructured":"Urish, K. L. et al. Antibiotic-tolerant Staphylococcus aureus biofilm persists on arthroplasty materials. Clin. Orthop. Relat. Res. 474, 1649\u20131656. https:\/\/doi.org\/10.1007\/s11999-016-4720-8 (2016).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"30951_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/jor.24291","volume":"37","author":"JB Mandell","year":"2019","unstructured":"Mandell, J. B. et al. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates. J. Orthop. Res. 37, 1604\u20131609. https:\/\/doi.org\/10.1002\/jor.24291 (2019).","journal-title":"J. Orthop. Res."},{"key":"30951_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/mBio.01658-19","volume":"10","author":"D Ma","year":"2019","unstructured":"Ma, D. et al. The toxin-antitoxin MazEF drives Staphylococcus aureus biofilm formation, antibiotic tolerance, and chronic infection. mBio 10, 19. https:\/\/doi.org\/10.1128\/mBio.01658-19 (2019).","journal-title":"mBio"},{"key":"30951_CR28","unstructured":"Clinical and Laboratory Standards Institute. M100: Performance Standards for Antimicrobial Susceptibility Testing."},{"key":"30951_CR29","unstructured":"Clinical and Laboratory Standards Institute. M07: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (2018)."},{"key":"30951_CR30","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. A simple method of estimating fifty per cent endpoints. Am. J. Hygeine 27, 493\u2013497 (1938).","journal-title":"Am. J. Hygeine"},{"key":"30951_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/bjs.1800560902","volume":"56","author":"J Charnley","year":"1969","unstructured":"Charnley, J. & Eftekhar, N. Postoperative infection in total prosthetic replacement arthroplasty of the hip-joint. With special reference to the bacterial content of the air of the operating room. Br. J. Surg. 56, 641\u2013649. https:\/\/doi.org\/10.1002\/bjs.1800560902 (1969).","journal-title":"Br. J. Surg."},{"key":"30951_CR32","first-page":"287","volume":"21","author":"O Cirioni","year":"2013","unstructured":"Cirioni, O. et al. In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. Infez. Med. 21, 287\u2013295 (2013).","journal-title":"Infez. Med."},{"key":"30951_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1407.R1","volume":"101","author":"CC Wyles","year":"2019","unstructured":"Wyles, C. C. et al. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: The value of allergy testing for antibiotic prophylaxis. Bone Jt. J. 101, 9\u201315 (2019).","journal-title":"Bone Jt. J."},{"key":"30951_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/cid\/cix794","volume":"66","author":"KG Blumenthal","year":"2018","unstructured":"Blumenthal, K. G. et al. The impact of a reported penicillin allergy on surgical site infection risk. Clin. Infect. Dis. 66, 329\u2013336. https:\/\/doi.org\/10.1093\/cid\/cix794 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"30951_CR35","doi-asserted-by":"publisher","first-page":"k2400","DOI":"10.1136\/bmj.k2400","volume":"361","author":"KG Blumenthal","year":"2018","unstructured":"Blumenthal, K. G. et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: Population based matched cohort study. BMJ 361, k2400. https:\/\/doi.org\/10.1136\/bmj.k2400 (2018).","journal-title":"BMJ"},{"key":"30951_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2009.01.034","volume":"122","author":"E Macy","year":"2009","unstructured":"Macy, E. & Poon, K. Y. T. Self-reported antibiotic allergy incidence and prevalence: Age and sex effects. Am. J. Med. 122, 778. https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.034 (2009).","journal-title":"Am. J. Med."},{"key":"30951_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jama.2017.6510","volume":"318","author":"JA Trubiano","year":"2017","unstructured":"Trubiano, J. A., Adkinson, N. F. & Phillips, E. J. Penicillin allergy is not necessarily forever. JAMA 318, 82\u201383. https:\/\/doi.org\/10.1001\/jama.2017.6510 (2017).","journal-title":"JAMA"},{"key":"30951_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/cid\/ciw795","volume":"64","author":"E Macy","year":"2017","unstructured":"Macy, E., Khan, D. A., Castells, M. C. & Lang, D. M. Penicillin allergy testing: A key component of antibiotic stewardship. Clin. Infect. Dis. 64, 531\u2013532. https:\/\/doi.org\/10.1093\/cid\/ciw795 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"30951_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/2047-783x-15-12-533","volume":"15","author":"KS Estes","year":"2010","unstructured":"Estes, K. S. & Derendorf, H. Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin. Eur. J. Med. Res. 15, 533\u2013543. https:\/\/doi.org\/10.1186\/2047-783x-15-12-533 (2010).","journal-title":"Eur. J. Med. Res."},{"key":"30951_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/14740330903413514","volume":"9","author":"ED Hermsen","year":"2010","unstructured":"Hermsen, E. D. et al. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert Opin. Drug Saf. 9, 9\u201314. https:\/\/doi.org\/10.1517\/14740330903413514 (2010).","journal-title":"Expert Opin. Drug Saf."},{"key":"30951_CR41","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","volume":"29","author":"MN Jeffres","year":"2007","unstructured":"Jeffres, M. N., Isakow, W., Doherty, J. A., Micek, S. T. & Kollef, M. H. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin. Ther. 29, 1107\u20131115. https:\/\/doi.org\/10.1016\/j.clinthera.2007.06.014 (2007).","journal-title":"Clin. Ther."},{"key":"30951_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1179\/joc.1997.9.6.420","volume":"9","author":"K Kralovicova","year":"1997","unstructured":"Kralovicova, K. et al. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients? J. Chemother. 9, 420\u2013426. https:\/\/doi.org\/10.1179\/joc.1997.9.6.420 (1997).","journal-title":"J. Chemother."},{"key":"30951_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.amjmed.2010.07.025","volume":"123","author":"L Pritchard","year":"2010","unstructured":"Pritchard, L. et al. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am. J. Med. 123, 1143\u20131149. https:\/\/doi.org\/10.1016\/j.amjmed.2010.07.025 (2010).","journal-title":"Am. J. Med."},{"key":"30951_CR44","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"SJ van Hal","year":"2013","unstructured":"van Hal, S. J., Paterson, D. L. & Lodise, T. P. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob. Agents Chemother. 57, 734\u2013744. https:\/\/doi.org\/10.1128\/AAC.01568-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"30951_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","volume":"37","author":"A Wong-Beringer","year":"2011","unstructured":"Wong-Beringer, A., Joo, J., Tse, E. & Beringer, P. Vancomycin-associated nephrotoxicity: A critical appraisal of risk with high-dose therapy. Int. J. Antimicrob. Agents 37, 95\u2013101. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.013 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"30951_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10096-010-1133-6","volume":"30","author":"O Rodriguez Colomo","year":"2011","unstructured":"Rodriguez Colomo, O. et al. Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function. Eur. J. Clin. Microbiol. Infect. Dis. 30, 635\u2013643. https:\/\/doi.org\/10.1007\/s10096-010-1133-6 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"30951_CR47","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","volume":"29","author":"MJ Rybak","year":"2009","unstructured":"Rybak, M. J. et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 29, 1275\u20131279. https:\/\/doi.org\/10.1592\/phco.29.11.1275 (2009).","journal-title":"Pharmacotherapy"},{"key":"30951_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak, M. J. et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am. J. Health Syst. Pharm. 77, 835\u2013864. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036 (2020).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"30951_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/phar.1638","volume":"35","author":"JP Prybylski","year":"2015","unstructured":"Prybylski, J. P. Vancomycin trough concentration as a predictor of clinical outcomes in patients with Staphylococcus aureus bacteremia: A meta-analysis of observational studies. Pharmacotherapy 35, 889\u2013898. https:\/\/doi.org\/10.1002\/phar.1638 (2015).","journal-title":"Pharmacotherapy"},{"key":"30951_CR50","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/cid\/ciz051","volume":"69","author":"DM Aljefri","year":"2019","unstructured":"Aljefri, D. M. et al. Vancomycin area under the curve and acute kidney injury: A meta-analysis. Clin. Infect. Dis. 69, 1881\u20131887. https:\/\/doi.org\/10.1093\/cid\/ciz051 (2019).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30951-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:13:17Z","timestamp":1679382797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30951-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30951"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30951-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"4 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4593"}}